Leukocytapheresis Therapy Improved Cholestasis in a Patient Suffering from Primary Sclerosing Cholangitis with Ulcerative Colitis

Primary sclerosing cholangitis (PSC) is an autoimmune disease of the hepatobiliary system for which effective therapy has not been established. Leukocytapheresis (LCAP) therapy is known to effective in patients with ulcerative colitis (UC). In addition, effects of LCAP therapy were reported on some...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Itou, Minoru, Mitsuyama, Keiichi, Kawaguchi, Takumi, Okabe, Yoshinobu, Suga, Hideya, Masuda, Junya, Yamasaki, Hiroshi, Kuwaki, Kotaro, Taniguchi, Eitaro, Harada, Masaru, Tsuruta, Osamu, Sata, Michio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: S. Karger AG 2009
Konular:
Published: April 2009
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2895181/
https://ncbi.nlm.nih.gov/pubmed/20651970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000210439
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller